Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan I So

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|December 4, 2009
Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell deathKai-xin Zhang, Yoshiyuki Matsui, Boris A Hadaschik, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 25, 2018
Natural history of prostatic lesions on serial multiparametric magnetic resonance imagingSamrad Ghavimi, Hamidreza Abdi, Jennifer Waterhouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
Biomacromolecules|March 2, 2011
In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancerClement Mugabe, Yoshiyuki Matsui, Alan I So, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
BJU International|June 1, 2023
A randomized controlled trial investigating rectus sheath catheters following radical cystectomyEdmund C P Chedgy, Raymond Tang, Werner J Struss, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 2, 2025
Examining the association between real-world extended vs. standard pelvic lymph node dissection and early and late oncologic outcomes in men undergoing radical prostatectomyWyatt MacNevin, Sandra Seo Young Kim, Ricardo A Rendon, et al.
Oncotarget|October 17, 2015
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathwayKyung Seok Han, Na Li, Pater A Raven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2011
In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancerClement Mugabe, Yoshiyuki Matsui, Alan I So, et al.
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|December 4, 2009
Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell deathKai-xin Zhang, Yoshiyuki Matsui, Boris A Hadaschik, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 25, 2018
Natural history of prostatic lesions on serial multiparametric magnetic resonance imagingSamrad Ghavimi, Hamidreza Abdi, Jennifer Waterhouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
Biomacromolecules|March 2, 2011
In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancerClement Mugabe, Yoshiyuki Matsui, Alan I So, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
BJU International|June 1, 2023
A randomized controlled trial investigating rectus sheath catheters following radical cystectomyEdmund C P Chedgy, Raymond Tang, Werner J Struss, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 2, 2025
Examining the association between real-world extended vs. standard pelvic lymph node dissection and early and late oncologic outcomes in men undergoing radical prostatectomyWyatt MacNevin, Sandra Seo Young Kim, Ricardo A Rendon, et al.
Oncotarget|October 17, 2015
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathwayKyung Seok Han, Na Li, Pater A Raven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2011
In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancerClement Mugabe, Yoshiyuki Matsui, Alan I So, et al.
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
Pageof 10